Biondo Investment Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History

Biondo Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$6.38 - $18.33 $1.16 Million - $3.35 Million	-182,555 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$12.38 - $19.1 $63,038 - $97,257	5,092 Added 2.87%	182,555 $3.04 Million
Q4 2021 Feb 08, 2022	BUY	$16.55 - $27.63 $10,360 - $17,296	626 Added 0.35%	177,463 $3.39 Million
Q3 2021 Nov 09, 2021	BUY	$20.35 - $26.63 $64,021 - $83,777	3,146 Added 1.81%	176,837 $4.36 Million
Q2 2021 Aug 03, 2021	BUY	$16.33 - $33.07 $15,219 - $30,821	932 Added 0.54%	173,691 $4.52 Million
Q1 2021 May 11, 2021	SELL	$28.67 - $52.59 $17,890 - $32,816	-624 Reduced 0.36%	172,759 $5.47 Million
Q4 2020 Feb 04, 2021	SELL	$28.04 - $50.26 $246,471 - $441,785	-8,790 Reduced 4.83%	173,383 $8.05 Million
Q3 2020 Nov 05, 2020	SELL	$27.75 - $36.3 $8,741 - $11,434	-315 Reduced 0.17%	182,173 $6 Million
Q2 2020 Aug 07, 2020	BUY	$27.21 - $41.0 $84,051 - $126,649	3,089 Added 1.72%	182,488 $5.01 Million
Q1 2020 May 08, 2020	SELL	$19.54 - $38.85 $91,564 - $182,051	-4,686 Reduced 2.55%	179,399 $5.37 Million
Q4 2019 Feb 06, 2020	SELL	$17.95 - $29.41 $13,462 - $22,057	-750 Reduced 0.41%	184,085 $5.1 Million
Q3 2019 Nov 05, 2019	BUY	$17.99 - $26.0 $3.33 Million - $4.81 Million	184,835 New	184,835 $3.36 Million

321

240M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.77B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Biondo Investment Advisors, LLC with notifications on news.